Orlistat 60 MG Oral Capsule — RxCUI 692876
RxNorm drug concept · Semantic clinical drug
RxCUI 692876
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI692876
Official nameOrlistat 60 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Orlistat: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Orlistat works by blocking some of the fat-digesting enzymes in your stomach and intestines. About 30% of the fat you eat at each meal doesn't get absorbed — it just passes out of...
- What exactly does orlistat do — and will it really help me lose weight?
- The oily stools, gas with discharge, and urgent or hard-to-control bowel movements happen because undigested fat has to go somewhere — and it exits in your stool. The more fat you...
- Why does orlistat cause those embarrassing bathroom side effects, and how do I prevent them?
🕸️ Concept Web — How Orlistat 60 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Orlistat 60 MG Oral Capsule
RxCUI 692876 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Orlistat
37925IN
-
Orlistat
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Alli
708361BN
-
Alli
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Orlistat Oral Capsule
373151SCDF -
Orlistat Oral Product
1159582SCDG -
Orlistat Pill
1159583SCDG -
Orlistat Oral Capsule [Alli]
723845SBDF -
Alli Oral Product
1168454SBDG -
Alli Pill
1168455SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Orlistat Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Orlistat 60 MG
692875SCDC -
Orlistat 60 MG Oral Capsule [Alli]
723846SBD -
Orlistat 60 MG [Alli]
723844SBDC
-
Orlistat 60 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Orlistat 60 MG
SCDC · 692875 -
Orlistat Oral Capsule
SCDF · 373151 -
Orlistat Oral Product
SCDG · 1159582 -
Orlistat Pill
SCDG · 1159583
Brand-Name Concepts
-
Orlistat 60 MG Oral Capsule [Alli]
SBD · 723846 -
Orlistat 60 MG [Alli]
SBDC · 723844 -
Orlistat Oral Capsule [Alli]
SBDF · 723845 -
Alli Oral Product
SBDG · 1168454 -
Alli Pill
SBDG · 1168455 -
Alli
BN · 708361
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 692876 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00135-0461-01 | 60 CAPSULE in 1 BOTTLE (0135-0461-01) | ALLI | Haleon US Holdings LLC | 2016-09-01 |
| 00135-0461-05 | 120 CAPSULE in 1 BOTTLE (0135-0461-05) | ALLI | Haleon US Holdings LLC | 2007-02-07 |
| 00135-0461-06 | 170 CAPSULE in 1 BOTTLE (0135-0461-06) | ALLI | Haleon US Holdings LLC | 2007-02-07 |
| 71610-0805-34 | 2280 CAPSULE in 1 BOTTLE (71610-805-34) | ALLI | Aphena Pharma Solutions - Tennessee, LLC | 2024-03-22 |
Observed labelers:
Haleon US Holdings LLC (3) ·
Aphena Pharma Solutions - Tennessee, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.